Literature DB >> 16492977

Lgl1 is suppressed in oxygen toxicity animal models of bronchopulmonary dysplasia and normalizes during recovery in air.

Katia Nadeau1, Robert P Jankov, A Keith Tanswell, Neil B Sweezey, Feige Kaplan.   

Abstract

Bronchopulmonary dysplasia (BPD), a major cause of morbidity in premature infants, is characterized by arrest of lung growth and inhibited alveologenesis. We had earlier cloned late-gestation lung 1 (LGL1), a glucocorticoid (GC)-induced, developmentally regulated gene in lung mesenchyme, and showed that reduced levels of late-gestation lung 1 protein (lgl1) inhibit lung branching. Maximal fetal expression of LGL1 is concordant with the onset of alveolar septation, suggesting an additional role for lgl1 in alveologenesis. At postnatal d 7, during the period of maximal septation in postnatal rat lung, lgl1 concentrates at the tips of budding secondary alveolar septa. We studied two models of impaired postnatal alveologenesis generated by exposure of newborn rats to 60% O2 for 2 wk or 95% O2 for 1 wk. A profound decrease of lgl1 expression with oxygen exposure was observed in both animal models. Animals exposed to 95% O2 for 1 wk recovered in air over a 3-wk period, associated with normalization of lgl1 levels. Changes in lung levels of alpha-actin (a marker of myofibroblast differentiation associated with alveologenesis) and the mesenchymal marker vimentin were significant but less marked. Our findings support a role for lgl1 in postnatal lung development. We speculate that deficiency of lgl1 contributes to the arrested alveolar partitioning observed in BPD and that recovery is associated with normalization of lgl1 levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492977     DOI: 10.1203/01.pdr.0000198819.81785.f1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

1.  Modulation of Lgl1 by steroid, retinoic acid, and vitamin D models complex transcriptional regulation during alveolarization.

Authors:  Katia Nadeau; Laura Montermini; Isabel Mandeville; Mousheng Xu; Scott T Weiss; Neil B Sweezey; Feige Kaplan
Journal:  Pediatr Res       Date:  2010-04       Impact factor: 3.756

2.  CRISPLD2 (LGL1) inhibits proinflammatory mediators in human fetal, adult, and COPD lung fibroblasts and epithelial cells.

Authors:  Hui Zhang; Alvin T Kho; Qing Wu; Andrew J Halayko; Karen Limbert Rempel; Robert P Chase; Neil B Sweezey; Scott T Weiss; Feige Kaplan
Journal:  Physiol Rep       Date:  2016-09

3.  Inflammatory cytokines, goblet cell hyperplasia and altered lung mechanics in Lgl1+/- mice.

Authors:  Jie Lan; Leslie Ribeiro; Isabel Mandeville; Katia Nadeau; Tim Bao; Salomon Cornejo; Neil B Sweezey; Feige Kaplan
Journal:  Respir Res       Date:  2009-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.